CFDs & Spread Betting with Accendo Markets
Mike van Dulken, Head of Research at Accendo Markets, commented: AstraZeneca (AZN) shares are today registering their first bounce in 7 days as investors react to the positive news that the pharmaceutical giant has increased FY 2012 earnings guidance from $6.00 to $6.30 per share. This comes on the back of the group announcing a…
CFDs & Spread Betting with Accendo Markets
CFDs & Spread Betting with Accendo Markets
CFDs & Spread Betting with Accendo Markets
Spread Betting with Accendo Markets